BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 6128251)

  • 21. Lergotrile mesylate: an in vivo dopamine agonist which blocks dopamine receptors in vitro.
    Kebabian JW; Calne DB; Kebabian PR
    Commun Psychopharmacol; 1977; 1(4):311-8. PubMed ID: 615694
    [No Abstract]   [Full Text] [Related]  

  • 22. [Biochemical mechanism of action of neuroleptics (author's transl)].
    Scatton B
    Encephale; 1981; 7(3):201-14. PubMed ID: 6116590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Schizophrenia.
    Bladessarini RJ
    N Engl J Med; 1977 Nov; 297(18):988-95. PubMed ID: 20577
    [No Abstract]   [Full Text] [Related]  

  • 24. [Characteristics and functions of intraneuronal compartments of monoamines in the central nervous system].
    Gowinski J; Besson MJ; Cheramy A; Javoy F; Thierry AM
    Rev Neurol (Paris); 1972 Jul; 127(1):1-22. PubMed ID: 4677511
    [No Abstract]   [Full Text] [Related]  

  • 25. Antipsychotic drug action: clinical, biochemical, and pharmacological evidence for site specificity of action.
    Borison RL; Hitri A; Blowers AJ; Diamond BI
    Clin Neuropharmacol; 1983 Jun; 6(2):137-50. PubMed ID: 6133618
    [No Abstract]   [Full Text] [Related]  

  • 26. [Biochemistry of schizophrenia and mechanism of action of neuroleptics].
    Loo H; Cuche H; Sechter D
    Sem Hop; 1982 Dec; 58(44):2565-72. PubMed ID: 6130604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biochemical characteristics of D1 dopamine receptors: relationship to behavior and schizophrenia.
    Creese I; Hess EJ
    Clin Neuropharmacol; 1986; 9 Suppl 4():14-6. PubMed ID: 2882838
    [No Abstract]   [Full Text] [Related]  

  • 28. [Antipsychotic drug therapy for patients with behavioral and psychological symptoms of dementia(BPSD)].
    Kudo T
    Seishin Shinkeigaku Zasshi; 2007; 109(7):657-63. PubMed ID: 17969953
    [No Abstract]   [Full Text] [Related]  

  • 29. Further evidence for the existence of multiple receptors for dopamine in the central nervous system.
    Iversen LL; Quik M; Emson PC; Dowling JE; Watling KJ
    Adv Biochem Psychopharmacol; 1980; 21():193-202. PubMed ID: 6103646
    [No Abstract]   [Full Text] [Related]  

  • 30. Multiple forms of the D1 dopamine receptor: its linkage to adenylate cyclase and psychopharmacological effects.
    Mailman RB; Schulz DW; Kilts CD; Lewis MH; Rollema H; Wyrick S
    Psychopharmacol Bull; 1986; 22(3):593-8. PubMed ID: 2879302
    [No Abstract]   [Full Text] [Related]  

  • 31. How do antipsychotic drugs work?
    Iversen LL
    Neurosci Res Program Bull; 1975 Aug; 13 Suppl():29-51. PubMed ID: 241033
    [No Abstract]   [Full Text] [Related]  

  • 32. Antipsychotic drugs: importance of dopamine receptors for mechanisms of therapeutic actions and side effects.
    Strange PG
    Pharmacol Rev; 2001 Mar; 53(1):119-33. PubMed ID: 11171942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurotensin receptors and dopamine transporters: effects of MPTP lesioning and chronic dopaminergic treatments in monkeys.
    Goulet M; Morissette M; Grondin R; Falardeau P; Bédard PJ; Rostène W; Di Paolo T
    Synapse; 1999 Jun; 32(3):153-64. PubMed ID: 10340626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Similarities and differences of dopamine receptors in the renal vascular bed and elsewhere.
    Goldberg LI; Volkman PH; Kohli JD; Kotake AN
    Adv Biochem Psychopharmacol; 1977; 16():251-6. PubMed ID: 196488
    [No Abstract]   [Full Text] [Related]  

  • 35. Dopamine system stabilizers, aripiprazole, and the next generation of antipsychotics, part 1, "Goldilocks" actions at dopamine receptors.
    Stahl SM
    J Clin Psychiatry; 2001 Nov; 62(11):841-2. PubMed ID: 11775041
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of chronic administration of dopaminergic blocking drugs on the level of enkephalins in the striatum and behavior of rats.
    Herman ZS; Trzeciak HI; Kowalski J; Obuchowicz E; Huzarska M
    Pol J Pharmacol Pharm; 1991; 43(5):421-32. PubMed ID: 1688094
    [No Abstract]   [Full Text] [Related]  

  • 37. Amygdaloid D1 receptors are not linked to stimulation of adenylate cyclase.
    Leonard SK; Anderson CM; Lachowicz JE; Schulz DW; Kilts CD; Mailman RB
    Synapse; 2003 Dec; 50(4):320-33. PubMed ID: 14556237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Behavioral activation developing after cessation of electrical stimulation of the caudate nucleus].
    Shishliannikova LV
    Fiziol Zh SSSR Im I M Sechenova; 1980 Aug; 66(8):1165-70. PubMed ID: 7191378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential actions of classical and atypical neuroleptics on mouse nigrostriatal neurons.
    Wood PL; McQuade PS; Etienne P; Lal S; Nair NP
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):765-8. PubMed ID: 6141617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of long-term neuroleptic administration on CNS receptors plasticity].
    Allikmets LKh; Zharkovskiĭ AM; Nurk AM; Vasar EE; Maĭmets MO
    Vestn Akad Med Nauk SSSR; 1984; (11):37-42. PubMed ID: 6152099
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.